Member Societies

• All
• Nov. 16 (Thu)
• Nov. 17 (Fri)
• Nov. 18 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Gut and Liver
• Insurance Policy

Symposium 01 : Distinguished research of 2023 in liver disease Korean

Date / Time	Nov. 16 (Thu), 09:00-10:20
Room	Vista 1
Chair(s)	Si Hyun Bae (The Catholic University of Korea, Korea) Yoon Jun Kim (Seoul National University, Korea)
Speakers	09:00-09:20	Viral hepatitis Beom Kyung Kim (Yonsei University, Korea)
	09:20-09:40	Alcoholic and nonalcoholic liver disease Hwi Young Kim (Ewha Womans University, Korea)
	09:40-10:00	Liver cirrhosis and complications Jeong Han Kim (Konkuk University, Korea)
	10:00-10:20	Hepatocellular carcinoma Ju Hyun Shim (University of Ulsan, Korea)

Special Lecture : Chung Yong Kim Memorial Lecture & General Meeting Korean

Date / Time	Nov. 16 (Thu), 11:00-11:30
Room	Vista 1
Chair	Kwang Cheol Koh (Sungkyunkwan University, Korea)
Speaker	11:00-11:30	Hepatic Fibrogenesis: From bench to bed? Kwan Sik Lee (CHA University, Korea)

Symposium 14 : Liver organoids and their applications for human liver diseases Korean

Date / Time	Nov. 16 (Thu), 13:30-14:50
Room	Vista 1
Chair(s)	Soon Koo Baik (Yonsei University, Korea) Jae Young Jang (Soonchunhyang University, Korea)
Speakers	13:30-13:50	Use of liver-on-a-chip for preclinical drug development and cell therapy Tae-Eun Park (Ulsan National Institute of Science and Technology (UNIST), Korea)
	13:50-14:10	Human pluripotent stem cell-derived liver organoids: from fabrication to application Myung Jin Son (Korea Research Institute of Bioscience and Biotechnology (KRIBB), Korea)
	14:10-14:30	Establishment of liver cancer organoids for enhanced treatment decision-making Jun Yong Park (Yonsei University, Korea)
	14:30-14:50	Applications of human iPSCs-derived organoids in practice: present and future perspectives Yong Kyun Kim (The Catholic University of Korea, Korea)

Symposium 16 : Efforts to achieve functional cure for chronic hepatitis B (CHB) Korean

Date / Time	Nov. 16 (Thu), 15:10-16:30
Room	Vista 1
Chair(s)	Yun Soo Kim (Gachon University, Korea) So Young Kwon (Konkuk University, Korea)
Speakers	15:10-15:30	Impact of HBsAg seroclearance in the long-term outcomes of CHB Hyun Yang (The Catholic University of Korea, Korea)
	15:30-15:50	Can finite NUC strategy increase the functional cure of CHB? Ju-Yeon Cho (Chosun University, Korea)
	15:50-16:10	Available biomarkers to predict functional cure Jihyun An (Hanyang University, Korea)
	16:10-16:30	Promising new treatment for functional cure Gwang Hyeon Choi (Seoul National University, Korea)

Free Paper 01: Liver 01 English

Date / Time	Nov. 16 (Thu), 10:40-11:20
Room	Vista 2
Chair(s)	Hee Bok Chae (Chungbuk National University, Korea) Hyung Joon Yim (Korea University, Korea)
Speakers	10:40-10:50	Outcomes of kidney transplantation from a Hepatitis B antigen positive donor to a Hepatitis B antigen negative recipient: a case series Joshua Vincent Baroña (National Kidney and Transplant Institute, Philippines)
		Withdrawal
	10:50-11:00	Discontinuation of antiviral therapy (AVT) even after 12 month-maintenance following hematopoietic stem cell transplantation (HSCT) is associated with the HBV reactivation in HBsAg-positive subjects Ji Won Han (The Catholic University of Korea, Korea)
	11:00-11:10	Longitudinal Changes in Renal Function in Chronic Hepatitis B Patients with Antiviral Treatment Hyeyeon Hong (University of Ulsan, Korea)

Free Paper 02: Liver 02 English

Date / Time	Nov. 16 (Thu), 11:20-12:00
Room	Vista 2
Chair(s)	Tae Hun Kim (Ewha Womans University, Korea) Byoung Kuk Jang (Keimyung University, Korea)
Speakers		Withdrawal
	11:20-11:30	Advancing Hepatitis C Virus Diagnostic Precision through Data Mining: A Comparative Analysis of Classification Models for Suspected Patients Rifaldy Fajar (Karlstad University, Sweden)
	11:30-11:40	Prevalence and Clinical Characteristics of Chronic Hepatitis C Among People Who Use Drugs (PWUDs) in Korea: A Prospective, Multicenter Study. Gwang Hyeon Choi (Seoul National University, Korea)
	11:40-11:50	Treatment Efficacy and Safety Profile of Sofosbuvir and Velpastavir based Treatement in South Korea: Multi-institutional Prospective Study Jae Hyun Yoon (Chonnam National University, Korea)

Free Paper 03: Liver 03 English

Date / Time	Nov. 16 (Thu), 13:30-14:10
Room	Vista 2
Chair(s)	Byeongseok Lee (Chungnam National University, Korea) Sang Hoon Ahn (Yonsei University, Korea)
Speakers	13:30-13:40	The Relationship between Steatotic Liver Disease and Its Newly Proposed Sub-classifications, and Coronary Artery Calcium Score Advancement Aryoung Kim (Sungkyunkwan University, Korea)
	13:40-13:50	Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in MetALD (MASLD and increased alcohol intake) Joo Hyun Oh (Eulji University, Korea)
	13:50-14:00	Association between sarcopenia and coronary atherosclerosis in patients with metabolic dysfunction-associated fatty liver disease Yeonjung Ha (CHA University, Korea)
	14:00-14:10	Portal Venous Pulsatility Index as a surrogate marker for Liver Fibrosis in NAFLD: Establishing a Nomogram Using Ultrasound Parameters Jaejun Lee (The Catholic University of Korea, Korea)

Free Paper 04: Liver 04 English

Date / Time	Nov. 16 (Thu), 14:10-14:50
Room	Vista 2
Chair(s)	June Sung Lee (Inje University, Korea) Tae Hee Lee (Konyang University, Korea)
Speakers	14:10-14:20	Solid Lipid Nanoparticle Ganodric acid ameliorates the High fat induced Nonalcoholic fatty liver disease via alteration Gut Microbiota and PI3K/AKT/mTOR Signaling pathway Deeksha Chauhan (Rajkamal Science & Management College, India)
	14:20-14:30	Risk of liver fibrosis associated with long-term methotrexate therapy in patients with psoriasis. A single-center retrospective study Ponthakorn Pichayanont (Sawanpracharak Hospital, Thailand)
	14:30-14:40	Adding kidney dysfunction type to the MELD-Na score does not provide better prognosis prediction compared to MELD 3.0 with albumin Kyeongmin Yeom (Soonchunhyang University, Korea)
	14:40-14:50	Comparison of Mortality Prediction between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) with Liver Cirrhosis in Korean Patients Seung Kang Yoo (Konkuk University, Korea)

Free Paper 12: Liver 05 English

Date / Time	Nov. 16 (Thu), 15:10-15:50
Room	Vista 2
Chair(s)	Changhyeong Lee (Daegu Catholic University, Korea) Jeong Heo (Pusan National University, Korea)
Speakers	15:10-15:20	Prediction of portal hypertension using non-invasive parameters; using 670 cirrhosis patients data. Seul Ki Han (Yonsei University Wonju, Korea)
	15:20-15:30	Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in patients with chronic hepatitis B and hepatitis C. Jiwon Kim (Korea University, Korea)
	15:30-15:40	Increased risk of osteoporotic fracture s in patients with primary biliary cholangitis Jonggi Choi (University of Ulsan, Korea)
	15:40-15:50	Effects of timing of endoscopy on clinical outcomes of cirrhotic patients with acute variceal bleeding in a tertiary hospital Alinda Mae Gordola (Philippine General Hospital, Philippines)

Free Paper 13: Liver 06 English

Date / Time	Nov. 16 (Thu), 15:50-16:30
Room	Vista 2
Chair(s)	Jaeseok Hwang (Keimyung University, Korea) Il Han Song (Dankook University, Korea)
Speakers	15:50-16:00	Real-world experience of atezolizumab plus bevacizumab combination treatment in high-risk patients with advanced hepatocellular carcinoma Jeong Heo (Pusan National University, Korea)
	16:00-16:10	Glycemic burden and the Outcome of Very Early and Early stage Hepatocellular Carcinoma treated with resection or ablation Hyun Joo Lee (Sungkyunkwan University, Korea)
	16:10-16:20	Early antibiotic exposure, but not late exposure, negatively affects the clinical outcome of first-line atezolizumab plus bevacizumab therapy in patients with hepatocellular carcinoma Aryoung Kim (Sungkyunkwan University, Korea)
	16:20-16:30	Liver function at the cessation of atezolizumab plus bevacizumab or lenvatinib as a determinant of survival in hepatocellular carcinoma Ji Won Han (The Catholic University of Korea, Korea)

Symposium 22 : Emerging issue on nonalcoholic fatty liver disease (NAFLD) English

Date / Time	Nov. 17 (Fri), 09:00-10:20
Room	Vista 2
Chair(s)	Sanghoon Park (Hallym University, Korea) Jin-Woo Lee (Inha University, Korea)
Speakers	09:00-09:20	Metabolic drugs in patients with NAFLD and diabetes: pioglitazone, GLP-1 agonist, and SGLT2 inhibitor Soon Sun Kim (Ajou University, Korea)
	09:20-09:40	Metabolic and genetic risk factors for NAFLD George Boon-Bee Goh (Singapore General Hospital, Singapore)
	09:40-10:00	Inter-organ crosstalk in the pathogenesis of NAFLD Dae Won Jun (Hanyang University, Korea)
	10:00-10:20	Risk factors and prognosis of NAFLD-related hepatocellular carcinoma Sang Bong Ahn (Eulji University, Korea)

Symposium 26 : Recent updates of cellular mechanisms and antifibrotic therapy in liver fibrosis Korean

Date / Time	Nov. 17 (Fri), 10:40-12:00
Room	Vista 2
Chair(s)	Won Young Tak (Kyungpook National University, Korea) Neung Hwa Park (University of Ulsan, Korea)
Speakers	10:40-11:00	Mechanisms of fibrosis progression: factors activating intrahepatic macrophages Hyuk Soo Eun (Chungnam National University, Korea)
	11:00-11:20	Crosstalk between stellate cells and immune cells in liver fibrosis Young-Sun Lee (Korea University, Korea)
	11:20-11:40	Roles of sinusoidal endothelial cells in liver fibrosis and portal hypertension Moon Young Kim (Yonsei University Wonju, Korea)
	11:40-12:00	Therapeutic advances in anti-fibrosis therapy in chronic liver diseases Seung Kak Shin (Gachon University, Korea)

Symposium 29 : Key questions on the management of hepatocellular carcinoma English

Date / Time	Nov. 17 (Fri), 13:30-14:50
Room	Vista 2
Chair(s)	Hyunchul Rhim (Sungkyunkwan University, Korea) Jongyoung Choi (The Catholic University of Korea, Korea)
Speakers	13:30-13:50	HCC surveillance for non-cirrhotic patients: the target population and surveillance tool Do Young Kim (Yonsei University, Korea)
	13:50-14:10	Selection of curative options for oligometastasis from HCC Wonseok Kang (Sungkyunkwan University, Korea)
	14:10-14:30	Early switch to or frontline systemic therapy for intermediate stage HCC Yuri Cho (National Cancer Center, Korea)
	14:30-14:50	Biomarker-based precision care of systemic therapy in HCC Stephen Chan (The Chinese University of Hong Kong, Hong Kong)

Symposium 32 : Controversial issue on liver disease Korean

Date / Time	Nov. 17 (Fri), 15:10-16:30
Room	Vista 2
Chair(s)	Joo Hyun Sohn (Hanyang University, Korea) Jong Eun Yeon (Korea University, Korea)
Speakers	15:10-15:30	Benign liver tumors: which to perform surgical resection and follow-up care? Jeong-Ju Yoo (Soonchunhyang University, Korea)
	15:30-15:50	When to test for hepatitis D virus and how to treat it? Young Eun Chon (CHA University, Korea)
	15:50-16:10	Ongoing issues in chronic hepatitis C: use of DAAs in HCC, reinfection, and surveillance after SVR Young Youn Cho (Chung-Ang University, Korea)
	16:10-16:30	Prevention and management of gastrointestinal bleeding during atezolizumab-bevacizumab for HCC Hee Yeon Kim (The Catholic University of Korea, Korea)

USG01 : Abdominal US training specialist 1 Korean

Date / Time	Nov. 18 (Sat), 09:00-10:30
Room	Walker 1
Chair	Sook-Hyang Jeong (Seoul National University, Korea)
Speakers	09:00-09:20	Useful tips to set up ultrasound rooms Moon Young Kim (Yonsei University Wonju, Korea)
	09:20-09:40	Ultrasound education for residents and fellows Seong Hee Kang (Korea University, Korea)
	09:40-10:00	How to write an abdominal ultrasound report Mi Na Kim (Yonsei University, Korea)
	10:00-10:20	How to perform liver biopsy Yu Rim Lee (Kyungpook National University, Korea)
	10:20-10:30	Q & A

USG02 : Abdominal US training specialist 2 Korean

Date / Time	Nov. 18 (Sat), 10:30-12:00
Room	Walker 1
Chair	Young Seok Kim (Soonchunhyang University, Korea)
Speakers	10:30-10:50	Application of doppler ultrasound in liver disease Jeong Eun Song (Daegu Catholic University, Korea)
	10:50-11:10	Application of microvascular imaging in hepatobiliary disease Jae Young Lee (Seoul National University, Korea)
	11:10-11:30	US guided procedures using various localization methods Dong Ho Lee (Seoul National University, Korea)
	11:30-11:50	Fibroscan and shear wave elastography Jeong-Ju Yoo (Soonchunhyang University, Korea)
	11:50-12:00	Q & A